Chronic Hepatitis C Infection as a Risk Factor for Renal Cell Carcinoma

Digestive Diseases and Sciences

Volumn 60, Issue 6, 2015, Pages 1820-1824

  Gonzalez, Humberto C ^a   Lamerato, Lois ^b   Rogers, Craig G ^c   Gordon, Stuart C ^b  

^a METHODIST UNIVERSITY HOSPITAL   (United States)

^b HENRY FORD HEALTH SYSTEM   (United States)

^c HENRY FORD HOSPITAL   (United States)

Author keywords

Extrahepatic manifestations; Hepatitis C; Prospective study; Renal cell carcinoma

Indexed keywords

ANTIVIRUS AGENT; HEPATITIS C ANTIBODY; VIRUS RNA;

ADULT; AGED; ANTIVIRAL THERAPY; ARTICLE; CANCER PATIENT; CANCER SCREENING; CHRONIC HEPATITIS C; COLON CANCER; COLORECTAL CANCER; CONTROLLED STUDY; CRYOABLATION; DIAGNOSTIC TEST ACCURACY STUDY; END STAGE RENAL DISEASE; FEMALE; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; KIDNEY CARCINOMA; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NEPHRECTOMY; PARTIAL NEPHRECTOMY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RENAL REPLACEMENT THERAPY; RISK FACTOR; UNITED STATES; VIREMIA; BLOOD; COMPLICATION; KIDNEY TUMOR; VIROLOGY;

AGED; CARCINOMA, RENAL CELL; FEMALE; HEPATITIS C ANTIBODIES; HEPATITIS C, CHRONIC; HUMANS; KIDNEY NEOPLASMS; MALE; MICHIGAN; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; RNA, VIRAL;

EID: 84930380077     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-015-3521-3     Document Type: Article

References (24)

1. Giordano TP, Henderson L, Landgren O, et al. Risk of non-Hodgkin lymphoma and lymphoproliferative precursor disease in US Veterans with hepatitis C virus. JAMA. 2007;297:2010–2017.
2. Hartridege-Lambert SK, Stein EM, Markowitz AJ, Portlock CS. Hepatitis C and non-Hodgkin lymphoma: the clinical perspective. Hepatology. 2012;55:634–641.
3. Dalrymple LS, Koepsell T, Sampson J, et al. Hepatitis C virus infection and the prevalence of renal insufficiency. Clin J Am Soc Neprhol. 2007;2:715–721.
4. Lipworth L, Tarone RE, McLaughlin JK, et al. The epidemiology of renal cell carcinoma. J Urol. 2006;176:2353–2358.
5. Sansonno D, Lauletta G, Montrone M, Grandaliano G, Schena FP, Dammacco F. Hepatitis C virus RNA and core protein in kidney glomerular and tubular structures isolated with laser capture microdissection. Clin Exp Immunol. 2005;140:498–506.
6. Di Micco B, Di Micco P. HCV and renal cell carcinoma: a new insight between HCV and oncogenesis? Report of five cases. Exp Oncol. 2003;25:77–778.
7. Fayek S, Moore D, Bortecen KH, et al. Liver transplantation in the setting of extra-hepatic malignancy: two case reports. Transpl Proc. 2007;39:3512–3514.
8. Garcia JH, Coelho GR, Cavalcante FP, et al. Synchronous hepatocellular carcinoma and renal cell carcinoma in a liver transplant recipient: a case report. Transplantation. 2007;84:1713.
9. Rifkin SI. Thirty-seven uninterrupted years of hemodialysis: a case report. Medscape J Med. 2008;10:231.
10. Gordon SC, Moonka D, Brown KA, et al. Risk of renal cell carcinoma in chronic hepatitis C infection. Cancer Epidemiol Biomark Prev. 2010;19:1066–1073.
11. Hofmann JN, Torner A, Chow WH, Ye W, Purdue MP, Duberg AS. Risk of kidney cancer and chronic kidney disease in relation to hepatitis C virus infection: a nationwide register-based cohort study in Sweden. Eur J Cancer Prev. 2011;20:326–330.
12. Budakoglu B, Aksoy S, Arslan C, et al. Frequency of HCV infection in renal cell carcinoma patients. Med Oncol. 2012;29:1892–1895.
13. Lee MH, Yang HI, Lu SN, et al. Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study. J Infect Dis. 2012;206:469–477.
14. Allison R. Increased risk of non-liver cancer mortality in persons with chronic hepatitis C infection, Chronic Hepatitis Cohort Study (CHeCS), 2006–2010. [Abstract] 2014. Presented at the American College of Preventive Medicine Conference, New Orleans, LA.
15. Macleod LC, Hotaling JM, Wright JL, et al. Risk factors for renal cell carcinoma in the VITAL study. J Urol. 2013;190:1657–1661.
16. Omland LH, Farkas DK, Jepsen P, Obel N, Pedersen L. Hepatitis C virus infection and risk of cancer: a population-based cohort study. Clin Epidemiol. 2010;2:179–186.
17. Mahajan R, Xing J, Liu SJ, et al. Mortality among persons in care with hepatitis C virus infection: The Chronic Hepatitis Cohort Study (CHeCS), 2006–2010. Clin Infect Dis. 2014;58:1055–1061.
18. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, through 2002. Ann Intern Med. 2006;144:705–714.
19. Ditah I, Ditah F, Devaki P, et al. The changing epidemiology of hepatitis C virus infection in the United States: National health and nutrition examination survey 2001 through 2010. J Hepatol. 2014;60:691–698.
20. Finell L, Miller JT, Tokars JI, Alter MJ, Arduinos M. National surveillance of dialysis-associated diseases in the United States, 2002. Semin Dial. 2005;18:52–61.
21. Fissell RB, Bragg-Gresham JL, Woods JD, et al. Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int. 2004;65:2335–2342.
22. Wiwanitkit V. Renal cell carcinoma and hepatitis C virus infection: Is there any cause-outcome relationship? Cancer Res Ther. 2011;7:226–227.
23. Nguyen MM, Gill IS, Ellison LM. The evolving presentation of renal carcinoma in the United States: trends from the surveillance, epidemiology, and end results program. J Urol. 2006;176:2397–2400.
24. Lee YC, Lee YL, Chuang JP, Lee JC. Difference in survival between colon and rectal cancer from SEER data. PLoS One. 2013;8:e78709.